Send this to a friend

Insulet moving to Acton, switching CEOs

Insulet, a manufacturer of the wearable OmniPod insulin system for diabetes patients, will move its worldwide headquarters in mid-December from Billerica to a $100-million Acton facility. CEO Patrick Sullivan will retire Dec. 31 and hand over the reigns to Shacey Petrovic, the firm's president and chief operating officer.
Why retire now?
Sullivan: When I first came to th ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media